CASAMENTO CHARLES J
SEC insider (Form 3/4/5 filer). CIK 0001117167. Director at Eton Pharmaceuticals, Inc. (ETON) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in DEERPARK, IL.
Companies CASAMENTO CHARLES J has filed insider reports for
- Eton Pharmaceuticals, Inc. (ETON): Director
- RELMADA THERAPEUTICS, INC. (RLMD): Director
- GT Biopharma, Inc. (GTBP): Director
CASAMENTO CHARLES J
CIK: 0001117167
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 31, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectCommon Stock
10K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
7.8K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
12.2K shares- - Dec 12, 2025RLMD
RELMADA THERAPEUTICS, INC.
AwardDirectStock Appreciation Rights
164K shares- - Sep 4, 2025GTBP
GT Biopharma, Inc.
AwardDirectOption to purchase Common Stock
62.5K shares- - Jun 26, 2025RLMD
RELMADA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
100K shares- - Jan 3, 2025ETON
Eton Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
25K shares- - Oct 22, 2024RLMD
RELMADA THERAPEUTICS, INC.
GiftDirect13K shares- - Sep 9, 2024RLMD
RELMADA THERAPEUTICS, INC.
PurchaseDirect13K shares at avg. $2.56$33K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 |  ETON Eton Pharmaceuticals, Inc. | Award Common Stock | 10,000 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Restricted Stock Units | 7,757 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 12,196 | - | - | Direct |
| Dec 12, 2025 |  RLMD RELMADA THERAPEUTICS, INC. | Award Stock Appreciation Rights | 164,000 | - | - | Direct |
| Sep 4, 2025 |  GTBP GT Biopharma, Inc. | Award Option to purchase Common Stock | 62,500 | - | - | Direct |
| Jun 26, 2025 | RLMD RELMADA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Oct 22, 2024 | RLMD RELMADA THERAPEUTICS, INC. | Gift | 13,000 | - | $0 | Direct |
| Sep 9, 2024 | RLMD RELMADA THERAPEUTICS, INC. | Purchase | 13,000 | $2.56 | $33,280 | Direct |
1-9 of 9 transactions